Manual versus nonmanual thrombectomy in primary and rescue percutaneous coronary angioplasty

Giandomenico Tarsia1, Mario De Michele, Domenico Polosa

  • 1Heart Department, San Carlo Hospital, Potenza, Italy.

Heart and Vessels
|August 3, 2010
PubMed

Insights

Manual thrombectomy devices are as effective as nonmanual devices for ST-segment elevation myocardial infarction (STEMI) treatment. Manual devices offer shorter procedure times and significant cost savings.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • ST-segment elevation acute myocardial infarction (STEMI) treatment often involves thrombectomy.
  • Comparative data on safety and effectiveness of different thrombectomy devices are limited.
  • No prior studies have directly compared manual versus nonmanual thrombectomy devices in STEMI patients.

Purpose of the Study:

  • To compare the safety and effectiveness of manual versus nonmanual thrombectomy devices in STEMI patients undergoing percutaneous coronary intervention (PCI).
  • To evaluate outcomes including ST-segment resolution, procedural complications, and clinical endpoints.

Main Methods:

  • Retrospective analysis of 232 consecutive STEMI patients undergoing PCI with thrombectomy devices.
  • Patients were divided into manual (n=110) and nonmanual (n=122) thrombectomy groups.
  • Primary endpoint: ST-segment resolution > or = 70%; secondary endpoints: angiographic, procedural, and clinical outcomes.

Main Results:

  • Similar rates of ST-segment resolution between manual (67.9%) and nonmanual (60.0%) groups (P=0.216).
  • No significant differences in procedural complications, reperfusion parameters, in-hospital MACE, or infarct size.
  • Manual thrombectomy showed better left ventricle ejection fraction at discharge.
  • Manual thrombectomy resulted in significantly shorter procedural times (69 vs 95 min, P<0.001) and lower costs (2981 vs 7505 euros, P<0.001).

Conclusions:

  • Manual thrombectomy devices are clinically equivalent to nonmanual devices for STEMI treatment via PCI.
  • Manual thrombectomy offers significant advantages in reduced procedural time and cost-effectiveness.
  • These findings support the consideration of manual thrombectomy devices in STEMI management.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...